FDA Warning Letter — Tris Pharma Inc.
The FDA took a Warning Letter action against Tris Pharma Inc. on March 28, 2018 (Monmouth Junction, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Tris Pharma Inc.
- Date
- March 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Monmouth Junction, NJ (United States)